Hear from Christopher as he describes his journey with focal segmental glomerulosclerosis (FSGS), from diagnosis and day-to-day with this rare kidney disease, to his work with NephCure Kidney International.
© 2021 Travere Therapeutics, Inc. All rights reserved. For US audiences. Chenodal®, Cholbam® and Total Care HUB® are registered trademarks of Travere Therapeutics, Inc. Thiola® and Thiola EC® are registered trademarks of Mission Pharmacal Company.
Travere President and Chief Executive Officer Eric Dube Featured in PharmaVOICE Trend Tracking
NewsApril 1, 2020 — The April edition of PharmaVOICE magazine features our CEO Eric Dube, Ph.D., along with other members of the PharmaVOICE 100 leadership community on their top priorities for the remainder of 2021 and the leadership skills that helped guide them through the pandemic.
View the digital edition >